Phase II Trial of Neoadjuvant Chemotherapy With Carboplatin and NAB-Paclitaxel in Patients With Locally Advanced and Inflammatory Triple Negative Breast Cancer.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Carboplatin; Paclitaxel
- Indications Breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- 13 Jul 2021 Biomarkers information updated
- 16 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Feb 2012 New trial record